Publication Information

{'id': 'https://openalex.org/W4283708346', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.3823', 'title': 'AB1307 RHEUMATIC SYNDROMES INDUCED BY ONCOLOGIC AND HEMATOLOGIC TARGETED THERAPIES', 'display_name': 'AB1307 RHEUMATIC SYNDROMES INDUCED BY ONCOLOGIC AND HEMATOLOGIC TARGETED THERAPIES', 'publication_year': 2022, 'publication_date': '2022-05-23', 'ids': {'openalex': 'https://openalex.org/W4283708346', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.3823'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.3823', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/1759.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/1759.2.full.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5008861132', 'display_name': 'José A. Gómez‐Puerta', 'orcid': 'https://orcid.org/0000-0001-8177-702X'}, 'institutions': [{'id': 'https://openalex.org/I4210115097', 'display_name': 'Hospital Clínic de Barcelona', 'ror': 'https://ror.org/02a2kzf50', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210115097']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'J. A. Gómez-Puerta', 'raw_affiliation_strings': ['Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I4210115097']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072501297', 'display_name': 'M. Tormo-Ratera', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802050225', 'display_name': 'Bellvitge University Hospital', 'ror': 'https://ror.org/00epner96', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I157913058', 'https://openalex.org/I2802050225', 'https://openalex.org/I4210153292']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'M. Tormo-Ratera', 'raw_affiliation_strings': ['Hospital de Bellvitge, Rheumatology, L’ Hospitalet de Llobregat, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital de Bellvitge, Rheumatology, L’ Hospitalet de Llobregat, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I2802050225']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028232743', 'display_name': 'Andrés Ponce', 'orcid': 'https://orcid.org/0000-0003-3068-5752'}, 'institutions': [{'id': 'https://openalex.org/I4210115097', 'display_name': 'Hospital Clínic de Barcelona', 'ror': 'https://ror.org/02a2kzf50', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210115097']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'A. Ponce Fernandez', 'raw_affiliation_strings': ['Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I4210115097']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112500449', 'display_name': 'Leandre Farrán', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802050225', 'display_name': 'Bellvitge University Hospital', 'ror': 'https://ror.org/00epner96', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I157913058', 'https://openalex.org/I2802050225', 'https://openalex.org/I4210153292']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'L. Farran', 'raw_affiliation_strings': ['Hospital de Bellvitge, Rheumatology, L’ Hospitalet de Llobregat, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital de Bellvitge, Rheumatology, L’ Hospitalet de Llobregat, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I2802050225']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089728477', 'display_name': 'Beatriz Frade‐Sosa', 'orcid': 'https://orcid.org/0000-0002-5867-8434'}, 'institutions': [{'id': 'https://openalex.org/I4210115097', 'display_name': 'Hospital Clínic de Barcelona', 'ror': 'https://ror.org/02a2kzf50', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210115097']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'B. Frade-Sosa', 'raw_affiliation_strings': ['Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I4210115097']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082782654', 'display_name': 'J. C. Sarmiento Monroy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210115097', 'display_name': 'Hospital Clínic de Barcelona', 'ror': 'https://ror.org/02a2kzf50', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210115097']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'J. C. Sarmiento Monroy', 'raw_affiliation_strings': ['Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital Clinic de Barcelona, Rheumatology, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I4210115097']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5008485597', 'display_name': 'Javier Narváez', 'orcid': 'https://orcid.org/0000-0002-1614-8064'}, 'institutions': [{'id': 'https://openalex.org/I2802050225', 'display_name': 'Bellvitge University Hospital', 'ror': 'https://ror.org/00epner96', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I157913058', 'https://openalex.org/I2802050225', 'https://openalex.org/I4210153292']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'J. Narváez', 'raw_affiliation_strings': ['Hospital de Bellvitge, Rheumatology, L’ Hospitalet de Llobregat, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital de Bellvitge, Rheumatology, L’ Hospitalet de Llobregat, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I2802050225']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.288, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.556131, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 60, 'max': 70}, 'biblio': {'volume': '81', 'issue': 'Suppl 1', 'first_page': '1759.2', 'last_page': '1760'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9987, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11725', 'display_name': 'Immunodeficiency and Autoimmune Disorders', 'score': 0.9957, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/targeted-therapy', 'display_name': 'Targeted Therapy', 'score': 0.5627806}, {'id': 'https://openalex.org/keywords/hematology', 'display_name': 'Hematology', 'score': 0.51236403}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.94796824}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.70349216}, {'id': 'https://openalex.org/C2781230642', 'wikidata': 'https://www.wikidata.org/wiki/Q492646', 'display_name': 'Targeted therapy', 'level': 3, 'score': 0.5627806}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.53832865}, {'id': 'https://openalex.org/C194409129', 'wikidata': 'https://www.wikidata.org/wiki/Q103824', 'display_name': 'Hematology', 'level': 2, 'score': 0.51236403}, {'id': 'https://openalex.org/C2778695046', 'wikidata': 'https://www.wikidata.org/wiki/Q421136', 'display_name': 'Sorafenib', 'level': 3, 'score': 0.48721093}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.45134658}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.35755613}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.32037035}, {'id': 'https://openalex.org/C2778019345', 'wikidata': 'https://www.wikidata.org/wiki/Q1148337', 'display_name': 'Hepatocellular carcinoma', 'level': 2, 'score': 0.10685828}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.3823', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/1759.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.3823', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/1759.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.84}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3084251940', 'https://openalex.org/W3023180431', 'https://openalex.org/W2762861864', 'https://openalex.org/W2593824244', 'https://openalex.org/W2558335336', 'https://openalex.org/W2396139388', 'https://openalex.org/W2211715327', 'https://openalex.org/W2133091679', 'https://openalex.org/W2063672847', 'https://openalex.org/W2057935885'], 'abstract_inverted_index': {'Background': [0], 'Targeted': [1, 177], 'therapy': [2, 9, 229], 'has': [3], 'gradually': [4], 'become': [5], 'the': [6, 58, 236, 345, 370, 373, 428], 'first-line': [7], 'clinical': [8, 288, 458], 'for': [10], 'solid': [11, 125], 'tumors': [12], 'and': [13, 85, 98, 123, 170, 196, 209, 226, 241, 279, 331, 363, 388, 417, 434, 443, 481, 487], 'hematologic': [14], 'disorders': [15, 122], '(1).': [16], 'Immune': [17], 'related': [18], 'adverse': [19], 'side': [20, 30, 42, 304, 432], 'effects': [21, 31, 43, 433], '(irAE)': [22], 'due': [23, 44, 303, 430], 'to': [24, 45, 56, 92, 431], 'checkpoint': [25], 'inhibitors': [26], 'are': [27, 49, 290], 'well': [28], 'recognized': [29], 'in': [32, 77, 132, 173, 182, 188, 193, 213, 223, 230, 257, 263, 267, 282, 292, 320, 324, 328, 333], 'patients': [33, 71, 81, 106, 119, 346, 378, 391, 401, 426], 'with': [34, 111, 403], 'underlying': [35], 'oncologic': [36, 351], 'disorders;': [37], 'however,': [38], 'information': [39], 'regarding': [40], 'rheumatic': [41, 60, 242, 251, 412, 459], 'several': [46], 'targeted': [47, 64, 239, 299, 404, 463], 'therapies': [48, 178, 240, 300, 464], 'rarely': [50], 'reported.': [51], 'Objectives': [52], 'Our': [53], 'aim': [54], 'was': [55, 219, 245], 'describe': [57], 'main': [59], 'syndromes': [61, 413, 460], 'induced': [62, 411, 461], 'by': [63, 462], 'therapies.': [65], 'Methods': [66], 'This': [67], 'observational': [68], 'study': [69], 'included': [70, 80, 108, 129, 179], 'from': [72, 83, 89, 235], '2': [73, 138, 143, 146, 194, 207, 264, 268, 271, 317, 321], 'referral': [74], 'University': [75], 'centers': [76], 'Barcelona.': [78], 'We': [79], 'referred': [82], 'Oncology': [84], 'Hematology': [86], 'departments': [87], 'visited': [88], 'January': [90, 93], '2017': [91], '2022': [94], 'at': [95], 'Hospital': [96, 99], 'Clinic': [97], 'de': [100], 'Bellvitge,': [101], 'Barcelona,': [102], 'Spain.': [103], 'Results': [104], 'Fifteen': [105], 'were': [107, 301, 308, 339], '(Female': [109], '60%),': [110], 'a': [112, 408], 'mean': [113], 'age': [114], '63.3±': [115], '10.8': [116], 'years.': [117], 'Nine': [118], 'had': [120, 355, 360, 366], 'hematological': [121], '8': [124, 296], 'tumors.': [126], 'Main': [127, 250, 287, 457], 'diagnosis': [128], 'Multiple': [130], 'Myeloma': [131], '3': [133, 189], '(20%)': [134], 'patients,': [135, 185, 260], 'Non-Hodgkin': [136], 'Lymphoma': [137], '(13%),': [139, 144, 147, 265, 269, 272, 318, 322], 'Acute': [140], 'Myeloid': [141], 'Leukemia': [142], 'Melanoma': [145], 'Colon': [148], 'carcinoma': [149, 153, 167], '1': [150, 154, 158, 163, 168, 174, 214, 283, 325, 329, 334], '(6.7%),': [151, 155, 159, 164, 326], 'Breast': [152], 'Glioblastoma': [156], 'multiforme': [157], 'Chronic': [160], 'lymphatic': [161], 'leukemia': [162], 'Renal': [165], 'cell': [166], '(6.7%)': [169, 175, 215, 284, 330, 335], 'Sésary': [171], 'Syndrome': [172], 'patient.': [176, 336], 'MAP': [180], 'kinases': [181], '4': [183, 258, 353, 389], '(26.7%)': [184], 'Anti': [186, 191], 'CD-38': [187], '(20%),': [190], 'BRAF': [192], '(13.3%),': [195], 'anti': [197, 199, 203], 'STAT-3,': [198], 'VEGF,': [200], 'BTK': [201], 'inhibitor,': [202], 'CCR4,': [204], 'Isocitrate': [205], 'dehydrogenase': [206], 'inhibitor': [208], 'Halichondrin': [210], 'B': [211], 'analoge': [212], 'patient': [216], 'each.': [217, 286], 'Treatment': [218], 'administrated': [220], 'as': [221, 227], 'monotherapy': [222], '9': [224], '(60%)': [225], 'combined': [228], '6': [231, 358, 376], '(40%).': [232], 'Mean': [233, 337], 'time': [234, 371], 'initiation': [237], 'of': [238, 344, 372, 400, 410, 425, 436, 466], 'syndrome': [243, 252, 307], 'onset': [244], '5.0': [246], '±': [247, 385], '3.8': [248], 'months.': [249, 342], 'were:': [253], 'Polymyalgia': [254], 'rheumatica': [255], '(PMR)': [256], '(26%)': [259, 354, 390], 'Raynaud’s': [261], 'phenomenon': [262], 'Tenosynovitis': [266], 'RA-like': [270], 'cutaneous': [273], 'vasculitis,': [274], 'amyopathic': [275], 'dermatomyositis,': [276], 'oligoarthritis,': [277], 'spondyloarthropathy-like': [278], 'non-inflammatory': [280], 'arthralgias': [281], 'case': [285], 'characteristics': [289], 'summarized': [291], 'Table': [293, 455], '1.': [294, 456], 'In': [295, 396], '(53%)': [297], 'cases,': [298], 'stopped': [302, 427], 'effects.': [305], 'Rheumatic': [306], 'treated': [309, 402], 'with,': [310], 'glucocorticoids': [311], '(GC)': [312], '12': [313], '(80%),': [314], 'calcium': [315], 'antagonist': [316], 'Hydroxychloroquine': [319], 'Methotrexate': [323], 'Sulfasalazine': [327], 'NSAID': [332], 'follow-up': [338], '15.4±': [340], '20': [341], 'Most': [343], 'remain': [347, 379], 'alive': [348], '(86%).': [349], 'According': [350], 'prognosis,': [352], 'complete': [356], 'response,': [357], '(40%)': [359, 377], 'partial': [361], 'response': [362], '5': [364], '(33%)': [365], 'disease': [367], 'progression.': [368], 'At': [369], 'last': [374], 'visit,': [375], 'on': [380, 392], 'GC': [381, 442], '(mean': [382], 'dose': [383], '6.7': [384], '4.7': [386], 'mg/d)': [387], 'DMARD': [393], 'therapy.': [394], 'Conclusion': [395], 'this': [397], 'heterogeneous': [398], 'group': [399], 'therapies,': [405], 'we': [406], 'described': [407], 'variety': [409], 'including': [414, 441], 'PMR,': [415], 'arthritis,': [416], 'even': [418], 'vasculitis': [419], 'or': [420], 'dermatomyositis.': [421], 'An': [422], 'important': [423], 'proportion': [424], 'treatment': [429, 440], 'some': [435], 'them': [437], 'required': [438], 'sustained': [439], 'DMARD.': [444], 'References': [445], '[1]Castelli': [446], 'MS': [447], 'et': [448], 'al.': [449], 'Pharmacol': [450], 'Res': [451], 'Perspect.': [452], '2019': [453], 'Dec;7(6):e00535.': [454], 'Disclosure': [465], 'Interests': [467], 'José': [468], 'A': [469], 'Gómez-Puerta': [470], 'Speakers': [471, 496, 506, 513], 'bureau:': [472, 497, 507, 514], 'Abbvie,': [473, 508], 'BMS,': [474], 'Galápagos,': [475, 485], 'GSK,': [476, 515], 'Janssen,': [477], 'Lilly,': [478, 498], 'MSD,': [479], 'Pfizer': [480], 'Roche,': [482], 'Consultant': [483], 'of:': [484], 'Roche': [486], 'Sanofi,': [488], 'Marian': [489], 'Tormo-Ratera:': [490], 'None': [491, 502, 518], 'declared,': [492, 503], 'ANDRES': [493], 'PONCE': [494], 'FERNANDEZ': [495], 'Novartis,': [499], 'Laura': [500], 'Farran:': [501], 'Beatriz': [504], 'Frade-Sosa': [505], 'Juan': [509], 'Camilo': [510], 'Sarmiento': [511], 'Monroy': [512], 'J.': [516], 'Narváez:': [517], 'declared': [519]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4283708346', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}], 'updated_date': '2024-12-15T23:39:03.273121', 'created_date': '2022-06-30'}